tradingkey.logo
tradingkey.logo
Search

Upstream Bio Announces First Patient Dosed In Phase 2 Clinical Trial Of Verekitug

ReutersJul 8, 2025 11:26 AM
facebooktwitterlinkedin
View all comments0

- Upstream Bio Inc UPB.O:

  • UPSTREAM BIO ANNOUNCES FIRST PATIENT DOSED IN PHASE 2 CLINICAL TRIAL OF VEREKITUG IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

  • UPSTREAM BIO INC - DOSES FIRST PATIENT IN PHASE 2 COPD TRIAL

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI